Suppr超能文献

对多功能阳离子抗菌肽皮肤防御素B2的抗肿瘤作用机制研究表明,细胞表面糖胺聚糖部分参与其中。

Studies of the antitumor mechanism of action of dermaseptin B2, a multifunctional cationic antimicrobial peptide, reveal a partial implication of cell surface glycosaminoglycans.

作者信息

Dos Santos Célia, Hamadat Sabah, Le Saux Karen, Newton Clara, Mazouni Meriem, Zargarian Loussiné, Miro-Padovani Mickael, Zadigue Patricia, Delbé Jean, Hamma-Kourbali Yamina, Amiche Mohamed

机构信息

Laboratoire (CRRET), EAC 7149 CNRS, University Paris Est Créteil, Créteil, France.

University Paris Est Créteil, Créteil, France.

出版信息

PLoS One. 2017 Aug 10;12(8):e0182926. doi: 10.1371/journal.pone.0182926. eCollection 2017.

Abstract

Dermaseptin-B2 (DRS-B2) is a multifunctional cationic antimicrobial peptide (CAP) isolated from frog skin secretion. We previously reported that DRS-B2 possesses anticancer and antiangiogenic activities in vitro and in vivo. In the present study, we evaluated the antiproliferative activity of DRS-B2 on numerous tumor cell lines, its cell internalization and studies of its molecular partners as well as their influences on its structure. Confocal microscopy using ([Alexa594]-(Cys0)-DRS-B2) shows that in sensitive human tumor cells (PC3), DRS-B2 seems to accumulate rapidly at the cytoplasmic membranes and enters the cytoplasm and the nucleus, while in less sensitive tumor cells (U87MG), DRS-B2 is found packed in vesicles at the cell membrane. Furthermore FACS analysis shows that PC3 cells viability decreases after DRS-B2 treatment while U87 MG seems to be unaffected. However, "pull down" experiments performed with total protein pools from PC3 or U87MG cells and the comparison between the antiproliferative effect of DRS-B2 and its synthetic analog containing all D-amino acids suggest the absence of a stereo-selective protein receptor. Pretreatment of PC3 cells with sodium chlorate, decreases the antiproliferative activity of DRS-B2. This activity is partially restored after addition of exogenous chondroitin sulfate C (CS-C). Moreover, we demonstrate that at nanomolar concentrations CS-C potentiates the antiproliferative effect of DRS-B2. These results highlight the partial implication of glycosaminoglycans in the mechanism of antiproliferative action of DRS-B2. Structural analysis of DRS-B2 by circular dichroism in the presence of increasing concentration of CS-C shows that DRS-B2 adopts an α-helical structure. Finally, structure-activity-relationship studies suggest a key role of the W residue in position 3 of the DRS-B2 sequence for its antiproliferative activity.

摘要

皮肤防御素-B2(DRS-B2)是一种从蛙皮分泌物中分离出来的多功能阳离子抗菌肽(CAP)。我们之前报道过DRS-B2在体外和体内均具有抗癌和抗血管生成活性。在本研究中,我们评估了DRS-B2对多种肿瘤细胞系的抗增殖活性、其细胞内化情况,研究了其分子伴侣以及它们对其结构的影响。使用([Alexa594]-(Cys0)-DRS-B2)的共聚焦显微镜显示,在敏感的人类肿瘤细胞(PC3)中,DRS-B2似乎在细胞质膜上迅速积累并进入细胞质和细胞核,而在不太敏感的肿瘤细胞(U87MG)中,DRS-B2被发现在细胞膜处的囊泡中聚集。此外,流式细胞术分析表明,DRS-B2处理后PC3细胞的活力降低,而U87MG细胞似乎未受影响。然而,用PC3或U87MG细胞的总蛋白库进行的“下拉”实验以及DRS-B2与其含所有D-氨基酸的合成类似物的抗增殖作用比较表明不存在立体选择性蛋白受体。用氯酸钠预处理PC3细胞会降低DRS-B2的抗增殖活性。添加外源性硫酸软骨素C(CS-C)后,该活性部分恢复。此外,我们证明在纳摩尔浓度下CS-C可增强DRS-B2的抗增殖作用。这些结果突出了糖胺聚糖在DRS-B2抗增殖作用机制中的部分作用。在CS-C浓度增加的情况下通过圆二色性对DRS-B2进行结构分析表明,DRS-B2呈现α-螺旋结构。最后,构效关系研究表明DRS-B2序列第3位的W残基对其抗增殖活性起关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/485b/5552233/d43aa07b7d11/pone.0182926.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验